AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32641090 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-min blind
Number of subjects: 500
Study 32641090 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 min with guidance
Number of subjects: 500
Study 34741564 — intervention group
Group type: EXPERIMENTAL
Intervention: CLS-TA
Number of subjects: 129
Study 34741564 — intervention group
Group type: COMPARATOR
Intervention: Control (rescue therapy)
Number of subjects: 129
Study 33772134 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Caries Removal (TCR)
Number of subjects: 120
Study 33772134 — intervention group
Group type: COMPARATOR
Intervention: Selective Caries Removal (SCR)
Number of subjects: 120
Study 33772134 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-surface restorations
Number of subjects: 120
Study 33772134 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-surface restorations
Number of subjects: 120
Study 36156456 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual visits using phentermine
Number of subjects: 100
Study 36156456 — intervention group
Group type: COMPARATOR
Intervention: In-person visits using phentermine
Number of subjects: 100
Study 34412653 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement‐to‐Music (M2M)
Number of subjects: 327
Study 34412653 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Exercise Training (SET)
Number of subjects: 327
Study 34412653 — intervention group
Group type: COMPARATOR
Intervention: Attention Control (AC)
Number of subjects: 327
Study 32762725 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status assessment using full MNA (Mini Nutritional Assessment)
Number of subjects: 326
Study 32762725 — intervention group
Group type: EXPERIMENTAL
Intervention: Living alone
Number of subjects: 326
Study 32762725 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple physical disabilities
Number of subjects: 326
Study 32762725 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic disease
Number of subjects: 326
Study 32762725 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial independency
Number of subjects: 326
Study 32762725 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional ability on ADL (Activities of Daily Living)
Number of subjects: 326
Study 32762725 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional ability on IADL (Instrumental Activities of Daily Living)
Number of subjects: 326
Study 32762725 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal cognitive status
Number of subjects: 326
Study 32762725 — intervention group
Group type: EXPERIMENTAL
Intervention: No frailty
Number of subjects: 326
Study 35032443 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily bathing with 2% chlorhexidine gluconate (CHG) detergent solution
Number of subjects: 1487
Study 35032443 — intervention group
Group type: COMPARATOR
Intervention: Daily bathing with pH neutral soap and water
Number of subjects: 1487
Study 33865308 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance exercises during daily tooth brushing (twice daily for three minutes over eight weeks)
Number of subjects: 51
Study 33865308 — intervention group
Group type: COMPARATOR
Intervention: Passive control group (no intervention)
Number of subjects: 51
Study 36096771 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections
Number of subjects: 105
Study 36096771 — intervention group
Group type: EXPERIMENTAL
Intervention: High molecular weight hyaluronic acid (HA) injections
Number of subjects: 105
Study 36096771 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of PRP and HA injections (PRP+HA)
Number of subjects: 105
Study 35109584 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal personalized lifestyle intervention (dietary and physical activity counseling and cognitive training) combined with dietary supplement epigallocatechin gallate (EGCG)
Number of subjects: 68
Study 35109584 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 68
Study 32873263 — intervention group
Group type: EXPERIMENTAL
Intervention: BPB (100 g)
Number of subjects: 70
Study 32873263 — intervention group
Group type: COMPARATOR
Intervention: PB (100 g)
Number of subjects: 70
Study 35395144 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months DAPT
Number of subjects: 307
Study 35395144 — intervention group
Group type: COMPARATOR
Intervention: 12 months DAPT
Number of subjects: 307
Study 33813559 — intervention group
Group type: EXPERIMENTAL
Intervention: Omidenepag isopropyl 0.002% once daily (QD)
Number of subjects: 98
Study 33813559 — intervention group
Group type: EXPERIMENTAL
Intervention: Omidenepag isopropyl 0.002% twice daily (BID)
Number of subjects: 98
Study 33813559 — intervention group
Group type: COMPARATOR
Intervention: Comparison of BID vs QD
Number of subjects: 98
Study 35253166 — intervention group
Group type: EXPERIMENTAL
Intervention: HSK3486
Number of subjects: 40
Study 35253166 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 40
Study 32696102 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tobramycin 0.3%/dexamethasone 0.1% plus ozonized oil eye drops, four times daily for seven days
Number of subjects: 80
Study 32696102 — intervention group
Group type: COMPARATOR
Intervention: Topical tobramycin 0.3%/dexamethasone 0.1% eye drops, four times daily for seven days
Number of subjects: 80
Study 32696102 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tobramycin 0.3%/dexamethasone 0.1% plus ozonized oil eye drops
Number of subjects: 80
Study 32696102 — intervention group
Group type: COMPARATOR
Intervention: Topical tobramycin 0.3%/dexamethasone 0.1% eye drops
Number of subjects: 80
Study 35191105 — intervention group
Group type: EXPERIMENTAL
Intervention: Accordion free gingival graft (FGG)
Number of subjects: 94
Study 35191105 — intervention group
Group type: COMPARATOR
Intervention: Conventional free gingival graft (FGG)
Number of subjects: 94
Study 34161053 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy followed by cytoreductive surgery/hyperthermic intraperitoneal chemotherapy and adjuvant chemotherapy
Number of subjects: 0
Study 35800020 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo NRT sampling group
Number of subjects: 517
Study 35800020 — intervention group
Group type: COMPARATOR
Intervention: Standard smoking cessation behavioral counseling group
Number of subjects: 517
Study 32760296 — intervention group
Group type: EXPERIMENTAL
Intervention: SKY Campus Happiness
Number of subjects: 131
Study 32760296 — intervention group
Group type: EXPERIMENTAL
Intervention: Foundations of Emotional Intelligence
Number of subjects: 131
Study 32760296 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction
Number of subjects: 131
Study 32760296 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention control group
Number of subjects: 131
Study 36038255 — intervention group
Group type: EXPERIMENTAL
Intervention: nHFOV
Number of subjects: 30
Study 36038255 — intervention group
Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 30
Study 32380522 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweets mentioning ReachOut organization
Number of subjects: 715
Study 32380522 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweets mentioning headspace organization
Number of subjects: 715
Study 32380522 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweets mentioning Young and Well Cooperative Research Centre organization
Number of subjects: 715
Study 32380522 — intervention group
Group type: COMPARATOR
Intervention: Randomly selected tweets (n=600)
Number of subjects: 715
Study 32380522 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweets authored by counterparts (n=115)
Number of subjects: 715
Study 32916500 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 G needle
Number of subjects: 20
Study 32916500 — intervention group
Group type: COMPARATOR
Intervention: 18 G needle
Number of subjects: 20
Study 32916500 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular ablation (FA)
Number of subjects: 20
Study 32916500 — intervention group
Group type: COMPARATOR
Intervention: CIDR-EB
Number of subjects: 20
Study 35915512 — intervention group
Group type: EXPERIMENTAL
Intervention: Engage‐PA
Number of subjects: 40
Study 35915512 — intervention group
Group type: COMPARATOR
Intervention: TAU+ (treatment‐as‐usual plus fitness tracker)
Number of subjects: 40
Study 34021309 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth tool and psychosocial support
Number of subjects: 120
Study 34021309 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth tool (app users)
Number of subjects: 120
Study 34021309 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth intervention
Number of subjects: 120
Study 34021309 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 120
Study 33436475 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus supervised high-intense exercise
Number of subjects: 0
Study 33436475 — intervention group
Group type: COMPARATOR
Intervention: Usual care plus health education (active control)
Number of subjects: 0
Study 33436475 — intervention group
Group type: COMPARATOR
Intervention: Usual care only (population-based control group)
Number of subjects: 0
Study 33033011 — intervention group
Group type: EXPERIMENTAL
Intervention: PGS2.0
Number of subjects: 268
Study 33033011 — intervention group
Group type: COMPARATOR
Intervention: Conventional embryo morphology evaluation (non-PGS)
Number of subjects: 268
Study 36260464 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory-adapted dental environment (SADE)
Number of subjects: 0
Study 36260464 — intervention group
Group type: COMPARATOR
Intervention: Regular dental environment
Number of subjects: 0
Study 33434447 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk score based on 297 single nucleotide polymorphisms
Number of subjects: 29663
Study 33434447 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous model of genetic risk score
Number of subjects: 29663
Study 33583335 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-fitted compression garments (CG)
Number of subjects: 11
Study 33583335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 33103453 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic exercise (HE; fraction of inspired oxygen 14.0%)
Number of subjects: 32
Study 33103453 — intervention group
Group type: COMPARATOR
Intervention: Normoxic exercise (NE)
Number of subjects: 32
Study 33103453 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic exercise (HE)
Number of subjects: 32
Study 33103453 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (H NE, P NE, H HE, P HE)
Number of subjects: 32
Study 32559794 — intervention group
Group type: EXPERIMENTAL
Intervention: Juice group (200 mL of liquid enriched with carbohydrate and protein 4 hours presurgery)
Number of subjects: 80
Study 32559794 — intervention group
Group type: COMPARATOR
Intervention: Control group (200 mL of inert solution 4 hours presurgery)
Number of subjects: 80
Study 34592862 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg oral thiamine for 12 weeks
Number of subjects: 0
Study 34592862 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-the-counter (OTC) oral thiamine after 6 months
Number of subjects: 0
Study 34592862 — intervention group
Group type: COMPARATOR
Intervention: No thiamine for 12 weeks
Number of subjects: 0
Study 34592862 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up after 6 months without restrictions
Number of subjects: 0
Study 33693586 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antipseudomonal antibiotics
Number of subjects: 249
Study 33693586 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous antipseudomonal antibiotics
Number of subjects: 249
Study 33693586 — intervention group
Group type: COMPARATOR
Intervention: Inhaled antipseudomonal antibiotics
Number of subjects: 249
Study 32481298 — intervention group
Group type: EXPERIMENTAL
Intervention: Qi Gui Yi Shen decoction
Number of subjects: 100
Study 32481298 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33849629 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 vaccine (inactivated, Vero cell)
Number of subjects: 13000
Study 33849629 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13000
Study 32703746 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-dose MCV vials
Number of subjects: 14
Study 32703746 — intervention group
Group type: COMPARATOR
Intervention: 10-dose MCV vials
Number of subjects: 14
Study 35940247 — intervention group
Group type: EXPERIMENTAL
Intervention: EXPECT (preoperative psychological intervention targeting patients' expectations)
Number of subjects: 567
Study 35940247 — intervention group
Group type: COMPARATOR
Intervention: SOC (Standard of Care)
Number of subjects: 567
Study 35940247 — intervention group
Group type: COMPARATOR
Intervention: SUPPORT (emotional support intervention without targeting expectations)
Number of subjects: 567
Study 35940247 — intervention group
Group type: EXPERIMENTAL
Intervention: EXPECT
Number of subjects: 567
Study 33079419 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital guided bone regeneration procedure
Number of subjects: 30
Study 32666061 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular bulk-fill composite resin
Number of subjects: 78
Study 32666061 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowable bulk-fill composite resin
Number of subjects: 78
Study 32666061 — intervention group
Group type: COMPARATOR
Intervention: Negative control group (enlarged root canals, no reinforcement)
Number of subjects: 78
Study 32666061 — intervention group
Group type: COMPARATOR
Intervention: Positive control group (root canals not enlarged)
Number of subjects: 78
Study 34973554 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Efficacy Prebriefing Model (SEPM)
Number of subjects: 66
Study 34973554 — intervention group
Group type: COMPARATOR
Intervention: Standard prebriefing
Number of subjects: 66
Study 32546240 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes conversation map (DCM)
Number of subjects: 123
Study 32546240 — intervention group
Group type: COMPARATOR
Intervention: Routine counselling (RC)
Number of subjects: 123
Study 36494209 — intervention group
Group type: EXPERIMENTAL
Intervention: External graft support
Number of subjects: 224
Study 34210922 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe vera toothpaste for 30 days
Number of subjects: 20
Study 34210922 — intervention group
Group type: COMPARATOR
Intervention: Fluoride toothpaste for 30 days
Number of subjects: 20
Study 32798329 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (9-week duration)
Number of subjects: 267
Study 32798329 — intervention group
Group type: COMPARATOR
Intervention: Education programme (5-week duration)
Number of subjects: 267
Study 34261990 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper body resistance exercise (EX)
Number of subjects: 16
Study 34261990 — intervention group
Group type: COMPARATOR
Intervention: Time-matched period (CON)
Number of subjects: 16
Study 34596156 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed magnetic therapy
Number of subjects: 45
Study 34596156 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise
Number of subjects: 45
Study 34596156 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined magnetic therapy and exercise therapy
Number of subjects: 45
Study 34596156 — intervention group
Group type: COMPARATOR
Intervention: Routine medical treatment (Control)
Number of subjects: 45
Study 32379396 — intervention group
Group type: EXPERIMENTAL
Intervention: Small Incision group
Number of subjects: 44
Study 32379396 — intervention group
Group type: COMPARATOR
Intervention: Long Incision group
Number of subjects: 44
Study 35917985 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver Nanoparticles (AgNPs) alone at 0.04%
Number of subjects: 0
Study 35917985 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver Nanoparticles (AgNPs) + Calcium Hydroxide (Ca(OH)2) at 0.03%
Number of subjects: 0
Study 35917985 — intervention group
Group type: COMPARATOR
Intervention: Triple antibiotic paste, Calcium Hydroxide, and Saline
Number of subjects: 0
Study 35917985 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing concentrations of Silver Nanoparticles (AgNPs)
Number of subjects: 0
Study 35917985 — intervention group
Group type: EXPERIMENTAL
Intervention: AgNPs (0.06%) + Calcium Hydroxide (Ca(OH)2)
Number of subjects: 0
Study 32394653 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Neiguan (PC 6) and Shuigou (GV 26) with disperse-dense wave, 2 Hz/100 Hz in frequency, 0.1-5 mA in intensity, treatment performed once a day for 14 consecutive days.
Number of subjects: 100
Study 32394653 — intervention group
Group type: COMPARATOR
Intervention: Control group treated with awakening drugs and neurotrophic drugs.
Number of subjects: 100
Study 32394653 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 100
Study 35418332 — intervention group
Group type: COMPARATOR
Intervention: Surgical mask (SM)
Number of subjects: 50
Study 35418332 — intervention group
Group type: COMPARATOR
Intervention: Filtering facepiece mask (FFP2)
Number of subjects: 50
Study 33965733 — intervention group
Group type: EXPERIMENTAL
Intervention: Denial
Number of subjects: 615
Study 33965733 — intervention group
Group type: COMPARATOR
Intervention: Decline to respond
Number of subjects: 615
Study 33965733 — intervention group
Group type: EXPERIMENTAL
Intervention: Attack the accuser
Number of subjects: 615
Study 33965733 — intervention group
Group type: EXPERIMENTAL
Intervention: Apology
Number of subjects: 615
Study 32406162 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling plus topical 4% tranexamic acid
Number of subjects: 60
Study 32406162 — intervention group
Group type: COMPARATOR
Intervention: Topical 4% hydroquinone
Number of subjects: 60
Study 32406162 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 33084980 — intervention group
Group type: EXPERIMENTAL
Intervention: Calsurf (bovine surfactant)
Number of subjects: 328
Study 33084980 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 328
Study 33483552 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebos (OLP) applied for 21 days
Number of subjects: 0
Study 33483552 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebos (OLP)
Number of subjects: 0
Study 35715486 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily mother-infant skin-to-skin contact (SSC) for one hour during the first five postnatal weeks
Number of subjects: 0
Study 35715486 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 0
Study 35715486 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily mother-infant skin-to-skin contact (SSC) (per-protocol analysis)
Number of subjects: 0
Study 35715486 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (per-protocol analysis)
Number of subjects: 0
Study 35715486 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily mother-infant skin-to-skin contact (SSC)
Number of subjects: 0
Study 33751906 — intervention group
Group type: EXPERIMENTAL
Intervention: l-theanine (single dose)
Number of subjects: 0
Study 33751906 — intervention group
Group type: EXPERIMENTAL
Intervention: l-theanine (regular intake for 12 weeks)
Number of subjects: 0
Study 33614993 — intervention group
Group type: EXPERIMENTAL
Intervention: Open narrative followed by closed questions
Number of subjects: 2509
Study 33614993 — intervention group
Group type: COMPARATOR
Intervention: Closed questions only
Number of subjects: 2509
Study 35258744 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm-mounted handle
Number of subjects: 9
Study 35258744 — intervention group
Group type: EXPERIMENTAL
Intervention: Joystick-and-trigger handle
Number of subjects: 9
Study 35258744 — intervention group
Group type: COMPARATOR
Intervention: Standard neurosurgical grasper (control)
Number of subjects: 9
Study 32321777 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative education comprising of a video and ICU tour in addition to standard care
Number of subjects: 100
Study 32321777 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study 32641334 — intervention group
Group type: EXPERIMENTAL
Intervention: IPCAS intervention involving a review of stroke-related needs, a self-management programme, a direct point of contact in general practice, enhanced communication between care services, and a directory of national and local community services.
Number of subjects: 0
Study 32641334 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group) for stroke patients.
Number of subjects: 0
Study 35219565 — intervention group
Group type: COMPARATOR
Intervention: Skin-only upper blepharoplasty
Number of subjects: 54
Study 35219565 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin/muscle upper blepharoplasty
Number of subjects: 54
Study 35219565 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 54
Study 35219565 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional muscle resection
Number of subjects: 54
Study 35476249 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganglionated plexi ablation
Number of subjects: 74
Study 35476249 — intervention group
Group type: COMPARATOR
Intervention: Maze procedure without ganglionated plexi ablation
Number of subjects: 74
Study 33926276 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 144
Study 33926276 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloons (DCB)
Number of subjects: 144
Study 33926276 — intervention group
Group type: EXPERIMENTAL
Intervention: PTA with mild dissection
Number of subjects: 144
Study 33926276 — intervention group
Group type: EXPERIMENTAL
Intervention: DCB with mild dissection
Number of subjects: 144
Study 33926276 — intervention group
Group type: EXPERIMENTAL
Intervention: PTA with severe dissection
Number of subjects: 144
Study 33926276 — intervention group
Group type: EXPERIMENTAL
Intervention: DCB with severe dissection
Number of subjects: 144
Study 35078833 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus care and case management (CCM) for 12 months
Number of subjects: 80
Study 35078833 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 80
Study 34096661 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial microcurrent stimulation (CMS); intensity, 25 μA; frequency, 8 Hz; 20-minute daily treatment for 2 weeks.
Number of subjects: 22
Study 34096661 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (no current).
Number of subjects: 22